Femtobiomed Inc. (XKON:327610)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,690.00
+10.00 (0.27%)
Last updated: May 12, 2025
-55.00%
Market Cap 28.91B
Revenue n/a
Net Income n/a
Shares Out 8.26M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 177
Average Volume 4,328
Open 3,690.00
Previous Close 3,680.00
Day's Range 3,690.00 - 3,690.00
52-Week Range 3,600.00 - 9,000.00
Beta 0.73
RSI 32.11
Earnings Date n/a

About Femtobiomed

Femtobiomed Inc. engages in the development of cargo-free intracellular delivery platform. The company, through its platform, CELLSHOT, is working on cell-based therapeutic pipelines. Its platform provides unprecedented approaches to cell therapeutics and cell biology research. The company was founded in 2011 and is based in Seongnam-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2011
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 327610
Full Company Profile

News

There is no news available yet.